Dyne Therapeutics Share Price Today
(NASDAQ: DYN)

Name: Dyne Therapeutics Share Price (NASDAQ: DYN) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Dyne Therapeutics share price is $11.82 & ₹997.71 as on 6 May 2025, 2.30 'hrs' IST

$11.82

▲

-0.04

(-0.34%)

Market is closed - opens 7 PM, 06 May 2025

View live Dyne Therapeutics share price in Dollar and Rupees. Guide to invest in Dyne Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Dyne Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Dyne Therapeutics share price movements

Today's Low: $11.36
Today's High: $11.96
$11.82
3.89%
Downside
Day's Volatility :5.02%
Upside
1.17%
52 Weeks Low: $6.36
52 Weeks High: $47.45
$11.82
46.19%
Downside
52 Weeks Volatility :86.6%
Upside
75.09%

Dyne Therapeutics (DYN) Returns

Period	Dyne Therapeutics, Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-19.81%	-6.7%	0.0%
6 Months	-58.56%	-6.3%	0.0%
1 Year	-54.82%	-1.6%	0.0%
3 Years	100.34%	6.4%	-5.5%

Dyne Therapeutics (DYN) Key Statistics

in dollars & INR

Previous Close	$11.86
Open	$11.39
Today's High	$11.96
Today's Low	$11.36
Market Capitalization	$1.3B
Today's Volume	$1.0M
52 Week High	$47.45
52 Week Low	$6.36
Revenue TTM	$0.0
EBITDA	$-342.2M
Earnings Per Share (EPS)	$-3.37
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-88.03%

How to invest in Dyne Therapeutics Stock (DYN) from India?

It is very easy for Indian residents to invest directly in Dyne Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Dyne Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Dyne Therapeutics or DYN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Dyne Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Dyne Therapeutics shares which would translate to 0.071 fractional shares of Dyne Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Dyne Therapeutics, in just a few clicks!

Returns in Dyne Therapeutics (DYN) for Indian investors in Rupees

The Dyne Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Dyne Therapeutics investment value today

Current value as on today

₹46,232

Returns

₹53,768

(-53.77%)

Returns from Dyne Therapeutics Stock

₹54,971 (-54.97%)

Dollar Returns

₹1,204 (+1.2%)

Indian investors sentiment towards Dyne Therapeutics (DYN)

92.0%

Period: Apr 5, 2025 to May 5, 2025. Change in 30 Days versus previous period

Investment in Dyne Therapeutics Shares from India has grown by 92.0% over the past 30 days, indicating increased transactional activity.

300%

Period: Apr 5, 2025 to May 5, 2025. Change in 30 Days versus previous period

Search interest for Dyne Therapeutics Stock from India on INDmoney has increased by 300% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Dyne Therapeutics

FMR Inc
7.04%
BlackRock Inc
7.00%
HHG PLC
6.49%
Vanguard Group Inc
5.90%
RA Capital Management, LLC
5.62%
FCPM III SERVICES BV
4.81%

Analyst Recommendation on Dyne Therapeutics

Rating

Trend

Buy

92%Buy

7%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Dyne Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Dyne Therapeutics Stock (DYN)

What analysts predicted

Upside of 304.88%

Target:

$47.86

Current:

$11.82

Insights on Dyne Therapeutics Stock (Ticker Symbol: DYN)

Price Movement
In the last 1 month, DYN stock has moved up by 43.2%
DYN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.3% return, outperforming this stock by 124.8%
DYN vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 89.7% return, outperforming this stock by 34.5%

Dyne Therapeutics Technicals Summary

Sell

Neutral

Buy

Dyne Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Dyne Therapeutics (DYN) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Dyne Therapeutics, Inc	58.34%	-58.56%	-54.82%	100.34%	-50.38%
Regeneron Pharmaceuticals, Inc.	5.73%	-26.98%	-36.83%	0.97%	8.18%
Beone Medicines Ltd	15.97%	22.95%	57.42%	90.56%	66.71%
Vertex Pharmaceuticals Incorporated	5.6%	0.25%	24.51%	113.24%	85.6%
Alnylam Pharmaceuticals, Inc.	11.35%	-2.22%	71.53%	111.71%	83.38%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Dyne Therapeutics, Inc	NA	NA	0.19	-3.48	-0.88	-0.5	NA	6.16
Regeneron Pharmaceuticals, Inc.	15.39	15.39	1.3	35.79	0.16	0.07	0.01	277.5
Beone Medicines Ltd	NA	NA	NA	1.06	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.37	17.94	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	1.07	-15.01	-0.02	NA	0.89

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Dyne Therapeutics, Inc	Buy	$1.3B	-50.38%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$65.4B	8.18%	15.39	31.94%
Beone Medicines Ltd	NA	$29.5B	66.71%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$128.8B	85.6%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$33.6B	83.38%	NA	-11.49%

Dyne Therapeutics Dividend announcements

Dyne Therapeutics Earnings
Dyne Therapeutics’s price-to-earnings ratio stands at None

About Dyne Therapeutics

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Organization	Dyne Therapeutics
Employees	191
CEO	Mr. John G. Cox M.B.A.
Industry	Commercial Services

Management People of Dyne Therapeutics

Name	Title
Mr. John G. Cox M.B.A.	CEO, President & Director
Dr. Oxana Beskrovnaya Ph.D.	Chief Innovation Officer
Ms. Johanna Friedl-Naderer	Chief Commercial Officer
Dr. Douglas Kerr M.B.A., M.D., Ph.D.	Chief Medical Officer
Mr. Erick J. Lucera C.F.A., CPA	CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer
Dr. Rajesh Manchanda Ph.D.	Chief Technical Officer
Mr. James P. Bilotta M.B.A.	Chief Digital & Information Officer
Dr. Ranjan Batra Ph.D.	Chief Scientific Officer
Mr. Daniel Wilson	Senior VP & Head of Legal
Ms. Lucia Celona	Chief Human Resource Officer

Important FAQs about investing in DYN Stock from India :

What is Dyne Therapeutics share price today?

Dyne Therapeutics share price today stands at $11.82, Open: $11.39 ; Previous Close: $11.86 ; High: $11.96 ; Low: $11.36 ; 52 Week High: $47.45 ; 52 Week Low: $6.36.

The stock opens at $11.39, after a previous close of $11.86. The stock reached a daily high of $11.96 and a low of $11.36, with a 52-week high of $47.45 and a 52-week low of $6.36.

Can Indians buy Dyne Therapeutics shares?

Yes, Indians can invest in the Dyne Therapeutics (DYN) from India.

With INDmoney, you can buy Dyne Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Dyne Therapeutics at zero transaction cost.

How can I buy Dyne Therapeutics shares from India?

It is very easy to buy Dyne Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Dyne Therapeutics (DYN) be purchased?

Yes, you can buy fractional shares of Dyne Therapeutics with INDmoney app.

What are the documents required to start investing in Dyne Therapeutics stocks?

To start investing in Dyne Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.